🇺🇸 FDA
Patent

US 7786137

Bicyclic derivatives as modulators of ion channels

granted A61PA61P1/02A61P1/04

Quick answer

US patent 7786137 (Bicyclic derivatives as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P1/02, A61P1/04, A61P19/02, A61P21/02